Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trialsResearch in context

Summary: Background: Whether there is a subset of patients with heart failure with preserved ejection fraction (HFpEF) that benefit from spironolactone therapy is unclear. We applied a machine learning approach to identify responders and non-responders to spironolactone among patients with HFpEF in...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Karl-Patrik Kresoja, Matthias Unterhuber, Rolf Wachter, Karl-Philipp Rommel, Christian Besler, Sanjiv Shah, Holger Thiele, Frank Edelmann, Philipp Lurz
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2023-10-01
Sarja:	EBioMedicine
Aiheet:	Machine learning Heart failure with preserved ejection fraction Spironolactone
Linkit:	http://www.sciencedirect.com/science/article/pii/S2352396423003614
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!